Clinical trial
Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With…
NCT00435019 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00435019 |
|---|---|
| Title | Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes |
| Official title | An Efficacy and Safety Comparison of Insulin Detemir vs. NPH Insulin in Children and Adolescents Diagnosed With Type 1 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin detemir, insulin NPH, insulin aspart |
| Enrollment | 348 |
| Start date | Feb 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 14, 2007 |
| Last update posted | Mar 10, 2017 |
| Countries | Bulgaria, Czechia, Denmark, Finland, France, Hungary, North Macedonia, Poland, Russia, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: